Exhibiting at VIV Asia 2025

Shandong Yakang Pharmaceutical Co., Ltd. is a leading Chinese manufacturer and exporter of veterinary pharmaceuticals, APIs (Active Pharmaceutical Ingredients), and feed additives. Based in Weifang, China, the company integrates research, development, production, and sales, focusing on veterinary health solutions with a growing global footprint. Yakang is recognized for its robust product portfolio, strong R&D capabilities, and commitment to quality standards in animal healthcare.

Company Background

Established with a mission to promote the healthy development of the livestock industry, Shandong Yakang Pharmaceutical has rapidly evolved into a significant contributor to veterinary drug manufacturing in China. The company has built a modern production base adhering to GMP standards and employs advanced technologies in its manufacturing and quality control processes.

Yakang leverages decades of experience and scientific research to deliver solutions that help enhance animal health, improve feed efficiency, and prevent disease outbreaks in livestock and poultry.

Core Business and Product Portfolio

Yakang’s offerings span across a comprehensive range of veterinary medicinal products, divided into key categories:

• Veterinary Active Pharmaceutical Ingredients (APIs)

  • Antibiotics: Oxytetracycline, Tylosin, Amoxicillin
  • Sulfonamides: Sulfamethazine, Sulfadiazine
  • Antipyretic Analgesics: Paracetamol, Dipyrone
  • Antivirals and Antiasthmatics
  • Quinolones: Enrofloxacin, Ciprofloxacin
  • Antiparasitics: Albendazole, Ivermectin
  • Vitamins: A, D, E complex

• Feed Additives

  • Amino Acids
  • Trace Minerals
  • Herbal Extracts and Enzyme Additives

• Veterinary Preparations

  • Injections, Powders, Oral Solutions, and Premixes

• Herbal and Traditional Chinese Medicine Extracts

  • Plant-based ingredients used for integrative veterinary solutions

These products are extensively used in poultry, swine, cattle, aquaculture, and pet health markets, both domestically and internationally.

Unique Selling Proposition (USP)

Shandong Yakang stands out through:

• A vertically integrated production model—from raw material API production to final drug formulations—ensuring quality control at every step.
• Strong export capabilities, with the company maintaining strategic relationships with distributors across more than 20 countries.
• Emphasis on Traditional Chinese Veterinary Medicine (TCVM), providing holistic solutions alongside conventional western formulations.
• Investments in green and environmentally friendly production processes, aligned with China's sustainability directives.

Financial & Export Performance

Although the company does not publicly disclose its full financials, trade data from platforms such as ImportYeti and Volza reveal consistent export activity:

• Shipment Insights (Volza): Shandong Yakang Pharmaceutical has exported veterinary APIs and formulations to Southeast Asia, the Middle East, Eastern Europe, and Africa.
• The company shows a pattern of repeat orders from international buyers, indicating high customer satisfaction and reliable supply chain performance.

These shipments primarily involve high-demand APIs like Enrofloxacin and Ivermectin, which are staples in veterinary treatment worldwide.

Target Market

Yakang targets:

• Veterinary drug distributors and wholesalers
• Animal feed producers
• Livestock and poultry farms
• Pharmaceutical contract manufacturers
• International buyers looking for OEM/ODM veterinary drugs

Their clients span across Asia-Pacific, Eastern Europe, Africa, and expanding into Latin America.

Capabilities

Yakang operates state-of-the-art production workshops that comply with GMP requirements. The company has established:

• A full-spectrum quality assurance system, including HPLC, GC, UV spectrophotometers, and microbiology testing facilities.
• R&D collaborations with universities and research institutes to promote new product development.
• Capacity to produce over 200 different veterinary APIs and preparations, allowing scalability and flexibility in supply.

Certifications and Compliance

Shandong Yakang Pharmaceutical complies with multiple industry standards:

• GMP Certification for Veterinary Drugs (Good Manufacturing Practice)
• ISO9001 Quality Management System
• HACCP Certification (Hazard Analysis Critical Control Point for feed additives)
• Products tested in alignment with USP, EP, and Chinese Veterinary Pharmacopeia

These certifications confirm Yakang’s commitment to product safety, regulatory compliance, and global market readiness.

Customer Testimonials

Though direct testimonials are limited in public sources, repeat order patterns and long-term distribution partnerships highlight:

• High product efficacy
• Reliability in delivery and documentation
• Positive reviews for regulatory support and documentation in export procedures

Achievements and Recognition

• Recognized in the Top 100 Veterinary Drug Enterprises in China
• Developed and commercialized over 50 proprietary formulations approved by China’s Ministry of Agriculture
• Expansion into green veterinary pharmaceuticals, supporting low-residue and eco-friendly animal treatments

Shandong Yakang Pharmaceutical Co., Ltd. continues to strengthen its global presence by delivering science-driven, high-quality veterinary pharmaceuticals tailored for the evolving needs of the animal health industry.